Roderick van den Bergh

Associate Professor Roderick van den Bergh (MD, PhD, FEBU) is a clinical urologist specializing in prostate cancer at Erasmus MC, Rotterdam, The Netherlands, and within the Anser prostate cancer network. He completed his urological training in the Utrecht region (2010–2015), followed by clinical fellowships at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre in Melbourne, Australia, and at the Netherlands Cancer Institute in Amsterdam (2015–2017). He subsequently worked for six years as a consultant urologist at St Antonius Hospital in Utrecht. His PhD research focused on active surveillance for low-risk prostate cancer within the PRIAS study, as part of the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Since then, he has been actively involved in clinical prostate cancer research, with more than 250 peer-reviewed publications. His main research interests include personalized prostate cancer screening, imaging, risk stratification, and the management of de novo metastatic prostate cancer. He is a full panel member of the European Association of Urology (EAU) Guidelines on Prostate Cancer and has been actively involved in the EAU Young Academic Urologists (YAU) Prostate Cancer Working Group. He is (co-)principal investigator of several prospective and randomized clinical trials and serves as an Associate Editor for European Urology Open Science, in addition to reviewing for leading international urology journals.